Anybody know about Galectin Therapeutics potential fibrosis medication??
Angel67 said
Oct 31, 2014
RudiRoo wrote:
Does anyone know anything about this? http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793988/
I saw an article about them last summer saying their stock had dropped and investors were considering legal action because they felt mislead. Now I see their stock is rising and they've had a paper accepted for this year's AALD conference.
Does anyone know fibrosis from fatty liver disease differ from Hep C fibrosis? They seem to be focusing on fatty liver disease but maybe because it's a bigger $$ target?
~Rudi
There seems to be an epidemic of Fatty livers in people of the western world. High fructose corn syrup may well be to blame in America? As I understand it, technically it can progress to fibrosis & then cirrhosis....technically. But in practise I doubt that many over eaters go on to get severe liver disease, I expect time will tell.
RudiRoo said
Oct 29, 2014
Does anyone know anything about this? http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793988/
I saw an article about them last summer saying their stock had dropped and investors were considering legal action because they felt mislead. Now I see their stock is rising and they've had a paper accepted for this year's AALD conference.
Does anyone know fibrosis from fatty liver disease differ from Hep C fibrosis? They seem to be focusing on fatty liver disease but maybe because it's a bigger $$ target?
There seems to be an epidemic of Fatty livers in people of the western world. High fructose corn syrup may well be to blame in America? As I understand it, technically it can progress to fibrosis & then cirrhosis....technically. But in practise I doubt that many over eaters go on to get severe liver disease, I expect time will tell.
Does anyone know anything about this? http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793988/
I saw an article about them last summer saying their stock had dropped and investors were considering legal action because they felt mislead. Now I see their stock is rising and they've had a paper accepted for this year's AALD conference.
Does anyone know fibrosis from fatty liver disease differ from Hep C fibrosis? They seem to be focusing on fatty liver disease but maybe because it's a bigger $$ target?
~Rudi